Neuroblastoma Treatment and Clinical Trials
Neuroblastoma treatment advancements through clinical trials
Over the years, many research studies (also known as clinical trials) have been conducted to understand the best ways to treat neuroblastoma. From these clinical trials, oncologists have established current standards for neuroblastoma treatment. Find more information on the current neuroblastoma treatment options.
Clinical trials may provide your child the opportunity to receive cutting-edge treatment. Children with neuroblastoma are living longer today because of past clinical trials that showed new treatments were safe and effective.
Evolution through Clinical Trials
Learn why clinical trials are important in neuroblastoma and why they may be an option for your child.
Evolution of high-risk neuroblastoma treatment
For example, in patients with high-risk neuroblastoma, the survival at diagnosis is reported to be about 50%.1 Clinical trials have shown that adding additional agents to the standard therapy improves survival in patients with treatment-responsive disease. The figure below highlights the evolution of high-risk neuroblastoma treatment through various studies. Of note, these studies represent specific patient populations, and these results cannot be extrapolated as a whole. It’s important to discuss with your child’s doctor what their specific prognosis and treatment will be.
To find out more about the clinical trials that inform the figure above, you can read the articles using the links below.
- Read the article by Dr DuBois published in the Journal of Clinical Oncology.
- Read the article by Dr Matthay published in the New England Journal of Medicine.
- Read the article by Dr Park published in the Journal of the American Medical Association.
References: 1. DuBois SG, Bagatell R. Improving outcomes in children with high-risk neuroblastoma: the role of randomized trials. J Clin Oncol. 2021. doi:10.1200/JCO.21.01066. 2. Matthay KK, Villablanca JG, Seeger RC, et al; for the Children's Cancer Group. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. N Engl J Med. 1999;341(16):1165-1173. 3. Park JR, Kreissman SG, London WB, et al. Effect of tandem autologous stem cell transplant vs single transplant on event-free survival in patients with high-risk neuroblastoma: a randomized clinical trial. JAMA. 2019;322(8):746-755.
Introduction to clinical trials
Clinical trials are research studies that test new ways to improve treatments in a group of people with a certain disease. In neuroblastoma, clinical trials often focus on new treatments to see if they are safer or more effective than what is currently available.
Clinical trials follow strict standards and are completely voluntary
- Clinical trials follow strict rules set by the Food and Drug Administration (FDA). These rules make sure that clinical trials are as safe as possible
- Participation in clinical trials is completely voluntary and you may choose to withdraw your child from a clinical trial at any time if you change your mind
Clinical trials are broken out by phases
The goal for a specific clinical trial will depend on the phase it's in.
- Phase 1: The purpose of a phase 1 clinical trial is to find a safe dose for the treatment being tested
- Phase 2: The purpose of a phase 2 clinical trial is to see how the treatment affects the body and fights cancer
- Phase 3: A phase 3 clinical trial generally tests the standard treatment against a new alternative treatment. The goal for this type of trial is to see if the new alternative treatment helps to increase cure rates, decrease side effects, or limit late effects of treatment
Clinical trials may vary based on location
Different hospitals are associated with different research organizations, so some clinical trials may only be available at certain hospitals. Learn more about the different research groups in neuroblastoma.
The decision to explore clinical trials or choose the current standard treatment is one that should be made along with your child’s oncologist. Because every neuroblastoma diagnosis is unique, your child’s oncologist can help you find the treatment best tailored to meet the needs of your child.